| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.819 | 0.001 | 0.819 | Thymidine kinase inhibitor | 0.351 0.002 DBMET00748 0.097 0.006 DBMET02125 | ||
| 0.777 | 0.003 | 0.883 | DNA synthesis inhibitor | 0.883 0.002 DBMET00748 0.363 0.028 DBMET02125 | DBMET00748 | |
| 0.721 | 0 | 0.721 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.346 0.001 DBMET00748 0.056 0.003 DBMET02125 | ||
| 0.685 | 0.003 | 0.685 | RNA-directed DNA polymerase inhibitor | 0.672 0.003 DBMET00748 0.377 0.021 DBMET02125 | ||
| 0.667 | 0.001 | 0.667 | Thymidine phosphorylase inhibitor | 0.385 0.001 DBMET00748 0.145 0.002 DBMET02125 | ||
| 0.651 | 0.004 | 0.683 | Cytidine deaminase inhibitor | 0.683 0.003 DBMET00748 0.186 0.054 DBMET02125 | DBMET00748 | |
| 0.63 | 0.001 | 0.63 | UDP-glucose 4-epimerase inhibitor | 0.601 0.001 DBMET00748 0.284 0.011 DBMET02125 | ||
| 0.643 | 0.031 | 0.643 | Caspase 9 stimulant | 0.401 0.11 DBMET00748 0.378 0.124 DBMET02125 | ||
| 0.605 | 0.002 | 0.605 | Antimetabolite | 0.426 0.003 DBMET00748 0.2 0.009 DBMET02125 | ||
| 0.545 | 0 | 0.545 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.109 0.002 DBMET00748 0.038 0.003 DBMET02125 | ||
| 0.517 | 0.004 | 0.561 | DNA polymerase I inhibitor | 0.561 0.003 DBMET00748 | DBMET00748 | |
| 0.506 | 0.001 | 0.506 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.481 0.001 DBMET00748 0.109 0.013 DBMET02125 | ||
| 0.499 | 0.005 | 0.607 | DNA methylase inhibitor | 0.607 0.004 DBMET00748 | DBMET00748 | |
| 0.526 | 0.034 | 0.596 | Antibacterial | 0.596 0.02 DBMET00748 0.222 0.204 DBMET02125 | DBMET00748 | |
| 0.484 | 0 | 0.484 | Uridine phosphorylase inhibitor | 0.447 0 DBMET00748 0.108 0.002 DBMET02125 | ||
| 0.487 | 0.006 | 0.487 | Adenylate cyclase inhibitor | 0.407 0.007 DBMET00748 0.133 0.057 DBMET02125 | ||
| 0.46 | 0.004 | 0.568 | NADH dehydrogenase inhibitor | 0.568 0.002 DBMET00748 0.116 0.031 DBMET02125 | DBMET00748 | |
| 0.45 | 0.005 | 0.45 | Interleukin 6 antagonist | 0.299 0.015 DBMET00748 0.133 0.118 DBMET02125 | ||
| 0.436 | 0.006 | 0.447 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.447 0.005 DBMET00748 | DBMET00748 | |
| 0.432 | 0.007 | 0.534 | DNA methyltransferase I inhibitor | 0.534 0.004 DBMET00748 | DBMET00748 | |
| 0.417 | 0.002 | 0.47 | Argininosuccinate synthase inhibitor | 0.47 0.002 DBMET00748 0.093 0.021 DBMET02125 | DBMET00748 | |
| 0.411 | 0.006 | 0.454 | Peptidyltransferase inhibitor | 0.454 0.004 DBMET00748 0.247 0.053 DBMET02125 | DBMET00748 | |
| 0.405 | 0.004 | 0.405 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.401 0.004 DBMET00748 0.149 0.027 DBMET02125 | ||
| 0.417 | 0.025 | 0.467 | DNA damaging | 0.467 0.017 DBMET00748 | DBMET00748 | |
| 0.383 | 0.009 | 0.383 | NOS3 expression enhancer | 0.375 0.009 DBMET00748 | ||
| 0.377 | 0.004 | 0.377 | DNA repair enzyme inhibitor | 0.363 0.004 DBMET00748 0.135 0.048 DBMET02125 | ||
| 0.4 | 0.05 | 0.476 | Immunostimulant | 0.476 0.032 DBMET00748 | DBMET00748 | |
| 0.355 | 0.005 | 0.355 | DNA directed RNA polymerase inhibitor | 0.226 0.011 DBMET00748 0.205 0.013 DBMET02125 | ||
| 0.419 | 0.108 | 0.805 | DNA directed DNA polymerase inhibitor | 0.805 0.019 DBMET00748 | DBMET00748 | |
| 0.338 | 0.029 | 0.338 | Cyclic AMP phosphodiesterase inhibitor | 0.294 0.044 DBMET00748 0.292 0.045 DBMET02125 | ||
| 0.369 | 0.066 | 0.369 | Vasodilator, peripheral | 0.307 0.094 DBMET00748 | ||
| 0.304 | 0.012 | 0.309 | Alkylator | 0.309 0.012 DBMET00748 | DBMET00748 | |
| 0.349 | 0.087 | 0.399 | Immunosuppressant | 0.399 0.063 DBMET00748 | DBMET00748 | |
| 0.257 | 0.007 | 0.381 | Phosphofructokinase-1 inhibitor | 0.381 0.003 DBMET00748 0.068 0.049 DBMET02125 | DBMET00748 | |
| 0.248 | 0.007 | 0.248 | AMP-activated protein kinase stimulant | 0.171 0.017 DBMET00748 0.148 0.029 DBMET02125 | ||
| 0.241 | 0.002 | 0.241 | Thymidylate synthase inhibitor | 0.166 0.003 DBMET00748 0.106 0.004 DBMET02125 | ||
| 0.309 | 0.077 | 0.309 | Immunomodulator | |||
| 0.235 | 0.008 | 0.235 | HIV-1 reverse transcriptase inhibitor | 0.221 0.008 DBMET00748 0.185 0.01 DBMET02125 | ||
| 0.359 | 0.134 | 0.359 | Apoptosis agonist | 0.256 0.208 DBMET00748 | ||
| 0.232 | 0.007 | 0.232 | Interleukin 8 antagonist | 0.11 0.076 DBMET00748 0.143 0.039 DBMET02125 | ||
| 0.297 | 0.076 | 0.297 | Interleukin 2 agonist | 0.294 0.078 DBMET00748 | ||
| 0.296 | 0.094 | 0.353 | Cholesterol antagonist | 0.353 0.063 DBMET00748 | DBMET00748 | |
| 0.202 | 0.005 | 0.202 | Phosphorylase inhibitor | 0.2 0.005 DBMET00748 | ||
| 0.22 | 0.029 | 0.481 | Alpha-N-acetylglucosaminidase inhibitor | 0.481 0.006 DBMET00748 0.165 0.047 DBMET02125 | DBMET00748 | |
| 0.192 | 0.006 | 0.239 | Biliverdin reductase inhibitor | 0.239 0.004 DBMET00748 0.144 0.01 DBMET02125 | DBMET00748 | |
| 0.209 | 0.03 | 0.311 | Hexokinase inhibitor | 0.311 0.01 DBMET00748 | DBMET00748 | |
| 0.156 | 0.008 | 0.156 | Carbonic anhydrase VB inhibitor | 0.072 0.026 DBMET00748 0.048 0.047 DBMET02125 | ||
| 0.156 | 0.017 | 0.167 | Aminoacyl-tRNA synthetase inhibitor | 0.167 0.015 DBMET00748 | DBMET00748 | |
| 0.148 | 0.011 | 0.207 | Carbamoyl phosphate synthetase inhibitor | 0.207 0.007 DBMET00748 0.071 0.034 DBMET02125 | DBMET00748 | |
| 0.157 | 0.024 | 0.239 | Adenylate kinase inhibitor | 0.239 0.011 DBMET00748 0.136 0.033 DBMET02125 | DBMET00748 | |
| 0.145 | 0.013 | 0.164 | Ribonucleotide reductase inhibitor | 0.164 0.01 DBMET00748 | DBMET00748 | |
| 0.229 | 0.098 | 0.229 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.206 0.15 DBMET02125 | ||
| 0.145 | 0.016 | 0.145 | Carbonic anhydrase V inhibitor | 0.102 0.026 DBMET00748 | ||
| 0.153 | 0.025 | 0.153 | Protein kinase C mu inhibitor | 0.106 0.051 DBMET00748 | ||
| 0.14 | 0.013 | 0.14 | Carbonic anhydrase VA inhibitor | 0.105 0.023 DBMET00748 | ||
| 0.288 | 0.168 | 0.375 | Calcium channel L-type activator | 0.375 0.099 DBMET02125 | DBMET02125 | |
| 0.127 | 0.015 | 0.452 | Focal adhesion kinase 1 inhibitor | 0.452 0.003 DBMET02125 | DBMET02125 | |
| 0.128 | 0.018 | 0.128 | Adenosine A1 receptor antagonist | 0.091 0.025 DBMET00748 | ||
| 0.116 | 0.008 | 0.116 | Purinergic P2Y antagonist | 0.103 0.009 DBMET00748 | ||
| 0.15 | 0.041 | 0.169 | Topoisomerase I inhibitor | 0.169 0.035 DBMET00748 | DBMET00748 | |
| 0.112 | 0.004 | 0.158 | Adenosine deaminase inhibitor | 0.158 0.003 DBMET00748 | DBMET00748 | |
| 0.161 | 0.055 | 0.161 | Cell wall synthesis inhibitor | 0.155 0.061 DBMET00748 0.145 0.07 DBMET02125 | ||
| 0.139 | 0.039 | 0.175 | Mucolytic | 0.175 0.02 DBMET00748 | DBMET00748 | |
| 0.178 | 0.081 | 0.209 | Hepatoprotectant | 0.209 0.06 DBMET00748 | DBMET00748 | |
| 0.124 | 0.028 | 0.124 | Thioredoxin inhibitor | 0.119 0.031 DBMET00748 | ||
| 0.106 | 0.016 | 0.108 | Protein kinase C eta inhibitor | 0.108 0.015 DBMET00748 | DBMET00748 | |
| 0.11 | 0.022 | 0.11 | Adenosine A3 receptor antagonist | 0.109 0.022 DBMET00748 | ||
| 0.111 | 0.026 | 0.317 | Glutamate dehydrogenase inhibitor | 0.317 0.005 DBMET00748 | DBMET00748 | |
| 0.113 | 0.033 | 0.113 | Phosphodiesterase 6D inhibitor | 0.102 0.048 DBMET00748 0.087 0.083 DBMET02125 | ||
| 0.199 | 0.122 | 0.248 | Interleukin agonist | 0.248 0.08 DBMET00748 | DBMET00748 | |
| 0.14 | 0.065 | 0.14 | Interleukin 1 antagonist | |||
| 0.124 | 0.049 | 0.124 | Protein kinase C gamma inhibitor | 0.104 0.071 DBMET00748 | ||
| 0.094 | 0.02 | 0.14 | Ribonucleoside-diphosphate reductase inhibitor | 0.14 0.013 DBMET00748 | DBMET00748 | |
| 0.107 | 0.033 | 0.152 | Transcription factor NF kappa B stimulant | 0.152 0.015 DBMET00748 | DBMET00748 | |
| 0.22 | 0.151 | 0.241 | Transcription factor NF kappa B inhibitor | 0.241 0.134 DBMET00748 | DBMET00748 | |
| 0.085 | 0.022 | 0.16 | Purinergic P2X1 antagonist | 0.16 0.006 DBMET00748 | DBMET00748 | |
| 0.218 | 0.156 | 0.254 | Antithrombotic | 0.254 0.123 DBMET00748 | DBMET00748 | |
| 0.115 | 0.054 | 0.164 | Expectorant | 0.164 0.03 DBMET00748 | DBMET00748 | |
| 0.084 | 0.024 | 0.084 | Protein kinase C beta inhibitor | 0.084 0.025 DBMET00748 | ||
| 0.137 | 0.077 | 0.137 | Protein kinase C nu inhibitor | |||
| 0.072 | 0.014 | 0.087 | Adenine nucleotide translocase inhibitor | 0.087 0.006 DBMET00748 | DBMET00748 | |
| 0.211 | 0.153 | 0.211 | Caspase 3 stimulant | |||
| 0.065 | 0.009 | 0.139 | Fumarate hydratase inhibitor | 0.139 0.004 DBMET00748 0.03 0.029 DBMET02125 | DBMET00748 | |
| 0.078 | 0.022 | 0.133 | Ornithine carbamoyltransferase inhibitor | 0.133 0.011 DBMET00748 | DBMET00748 | |
| 0.059 | 0.008 | 0.059 | Purinergic P2Y2 antagonist | 0.05 0.01 DBMET00748 0.033 0.024 DBMET02125 | ||
| 0.193 | 0.144 | 0.203 | MAP kinase kinase 3 inhibitor | 0.203 0.114 DBMET02125 | DBMET02125 | |
| 0.284 | 0.235 | 0.569 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.569 0.012 DBMET02125 | DBMET02125 | |
| 0.134 | 0.087 | 0.134 | MAP3K9 inhibitor | |||
| 0.052 | 0.012 | 0.053 | Antibiotic Aminoglycoside-like | 0.053 0.012 DBMET00748 | DBMET00748 | |
| 0.049 | 0.009 | 0.049 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.049 0.009 DBMET00748 0.038 0.013 DBMET02125 | ||
| 0.046 | 0.011 | 0.053 | HCV NS5B polymerase inhibitor | 0.053 0.009 DBMET00748 | DBMET00748 | |
| 0.042 | 0.007 | 0.043 | Adenosine A1 receptor agonist | 0.043 0.007 DBMET00748 | DBMET00748 | |
| 0.039 | 0.007 | 0.039 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 DBMET00748 | ||
| 0.047 | 0.015 | 0.09 | Phosphoglycerate kinase inhibitor | 0.09 0.008 DBMET00748 | DBMET00748 | |
| 0.038 | 0.007 | 0.039 | Adenosine kinase inhibitor | 0.039 0.007 DBMET00748 | DBMET00748 | |
| 0.072 | 0.042 | 0.072 | Protein kinase C alpha inhibitor | |||
| 0.151 | 0.122 | 0.19 | Angiogenesis stimulant | 0.19 0.1 DBMET00748 | DBMET00748 | |
| 0.044 | 0.015 | 0.044 | CF transmembrane conductance regulator antagonist | 0.04 0.025 DBMET00748 0.039 0.032 DBMET02125 | ||
| 0.034 | 0.004 | 0.034 | Purinergic P2 agonist | 0.028 0.005 DBMET00748 | ||
| 0.034 | 0.004 | 0.034 | Purinergic receptor agonist | 0.028 0.005 DBMET00748 | ||
| 0.05 | 0.021 | 0.076 | Guanylate cyclase inhibitor | 0.076 0.004 DBMET00748 | DBMET00748 | |
| 0.044 | 0.016 | 0.044 | RNA-directed RNA polymerase inhibitor | 0.033 0.026 DBMET00748 | ||
| 0.028 | 0.001 | 0.028 | Purinergic P2Y2 agonist | 0.022 0.002 DBMET00748 0.01 0.009 DBMET02125 | ||
| 0.133 | 0.107 | 0.139 | Heat shock protein 70 antagonist | 0.133 0.106 DBMET00748 0.139 0.08 DBMET02125 | DBMET02125 | |
| 0.028 | 0.004 | 0.028 | Purinergic P2Y agonist | 0.023 0.005 DBMET00748 | ||
| 0.19 | 0.169 | 0.19 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.032 | 0.012 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.038 0.009 DBMET00748 | DBMET00748 | |
| 0.061 | 0.044 | 0.061 | Adenosine A2a receptor antagonist | |||
| 0.021 | 0.006 | 0.021 | Purinergic P2Y1 agonist | 0.019 0.007 DBMET00748 | ||
| 0.091 | 0.077 | 0.096 | Anabolic | 0.087 0.085 DBMET00748 0.096 0.069 DBMET02125 | DBMET02125 | |
| 0.198 | 0.184 | 0.237 | Vasodilator, coronary | 0.237 0.147 DBMET00748 | DBMET00748 | |
| 0.051 | 0.042 | 0.051 | Alpha-mannosidase inhibitor | 0.049 0.045 DBMET00748 | ||
| 0.01 | 0.001 | 0.01 | Purinergic P2Y6 agonist | 0.006 0.001 DBMET00748 | ||
| 0.023 | 0.014 | 0.027 | Isoleucine-tRNA ligase inhibitor | 0.027 0.008 DBMET00748 | DBMET00748 | |
| 0.049 | 0.041 | 0.061 | Protein 50S ribosomal subunit inhibitor | 0.061 0.03 DBMET00748 | DBMET00748 | |
| 0.018 | 0.009 | 0.018 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.018 0.01 DBMET00748 | ||
| 0.042 | 0.034 | 0.052 | AICAR transformylase inhibitor | 0.052 0.02 DBMET00748 0.05 0.022 DBMET02125 | DBMET00748 | |
| 0.016 | 0.009 | 0.017 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.017 0.008 DBMET00748 | DBMET00748 | |
| 0.018 | 0.011 | 0.019 | Adenosine A3 receptor agonist | 0.019 0.01 DBMET00748 | DBMET00748 | |
| 0.027 | 0.019 | 0.029 | Purinergic P2X agonist | 0.029 0.018 DBMET00748 | DBMET00748 | |
| 0.11 | 0.105 | 0.11 | Protein kinase stimulant | |||
| 0.015 | 0.01 | 0.015 | Adenosine A2b receptor agonist | 0.015 0.01 DBMET00748 | ||
| 0.056 | 0.053 | 0.056 | Adenosine A2 receptor antagonist | |||
| 0.048 | 0.045 | 0.126 | Acyl-CoA dehydrogenase inhibitor | 0.126 0.012 DBMET00748 | DBMET00748 | |
| 0.005 | 0.003 | 0.005 | Purinergic P2Y4 agonist | 0.004 0.003 DBMET00748 | ||
| 0.129 | 0.127 | 0.152 | Ca2+-transporting ATPase inhibitor | 0.137 0.085 DBMET00748 0.152 0.038 DBMET02125 | DBMET02125 | |
| 0.043 | 0.043 | 0.055 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.024 DBMET00748 | DBMET00748 | |
| 0.066 | 0.068 | 0.085 | Antineoplastic antibiotic | 0.085 0.054 DBMET00748 | DBMET00748 | |
| 0.039 | 0.042 | 0.045 | Mannosidase inhibitor | 0.045 0.032 DBMET00748 | DBMET00748 | |
| 0.009 | 0.014 | 0.012 | Purine nucleoside phosphorylase inhibitor | 0.012 0.008 DBMET02125 | DBMET02125 | |
| 0.076 | 0.084 | 0.137 | Triose-phosphate isomerase inhibitor | 0.137 0.024 DBMET00748 0.096 0.051 DBMET02125 | DBMET00748 | |
| 0.047 | 0.056 | 0.069 | Glucosylceramidase inhibitor | 0.069 0.023 DBMET00748 | DBMET00748 | |
| 0.046 | 0.055 | 0.124 | HIV-1 integrase (Strand Transfer) inhibitor | 0.124 0.016 DBMET00748 | DBMET00748 | |
| 0.05 | 0.062 | 0.125 | HIV-1 integrase (3'-Processing) inhibitor | 0.125 0.018 DBMET00748 | DBMET00748 | |
| 0.024 | 0.037 | 0.035 | DNA polymerase III inhibitor | 0.032 0.012 DBMET00748 0.035 0.008 DBMET02125 | DBMET02125 | |
| 0.015 | 0.03 | 0.02 | Methylmalonyl-CoA mutase inhibitor | 0.02 0.008 DBMET00748 | DBMET00748 | |
| 0.048 | 0.063 | 0.085 | Selectin antagonist | 0.085 0.034 DBMET00748 | DBMET00748 | |
| 0.047 | 0.063 | 0.079 | Androgen agonist | 0.079 0.024 DBMET02125 | DBMET02125 | |
| 0.058 | 0.076 | 0.082 | HIV-1 integrase inhibitor | 0.082 0.037 DBMET00748 | DBMET00748 | |
| 0.135 | 0.163 | 0.173 | Neurotrophic factor enhancer | 0.173 0.106 DBMET02125 | DBMET02125 | |
| 0.073 | 0.101 | 0.238 | Uric acid excretion stimulant | 0.238 0.008 DBMET00748 | DBMET00748 | |
| 0.145 | 0.174 | 0.152 | MAP kinase kinase 5 inhibitor | 0.152 0.144 DBMET02125 | DBMET02125 | |
| 0.113 | 0.152 | 0.137 | Interferon gamma antagonist | 0.137 0.098 DBMET00748 | DBMET00748 | |
| 0.127 | 0.167 | 0.146 | Cyclin-dependent kinase 3 inhibitor | 0.146 0.106 DBMET02125 | DBMET02125 | |
| 0.067 | 0.112 | 0.109 | Interleukin 5 antagonist | 0.109 0.033 DBMET02125 | DBMET02125 | |
| 0.083 | 0.13 | 0.193 | CDK3/cyclin E inhibitor | 0.193 0.008 DBMET02125 | DBMET02125 | |
| 0.011 | 0.063 | 0.057 | Calcitonin gene-related peptide antagonist | 0.057 0.008 DBMET02125 | DBMET02125 | |
| 0.028 | 0.085 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.029 DBMET00748 | DBMET00748 | |
| 0.061 | 0.121 | 0.105 | Alcohol dehydrogenase inhibitor | 0.105 0.047 DBMET02125 | DBMET02125 | |
| 0.008 | 0.079 | 0.018 | Calcitonin gene-related peptide 1 receptor antagonist | 0.018 0.01 DBMET02125 | DBMET02125 | |
| 0.008 | 0.082 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.005 DBMET02125 | DBMET02125 | |
| 0.197 | 0.276 | 0.249 | MAP kinase kinase 6 inhibitor | 0.249 0.191 DBMET02125 | DBMET02125 | |
| 0.111 | 0.193 | 0.145 | Lipocortins synthesis antagonist | 0.145 0.113 DBMET00748 | DBMET00748 | |
| 0.033 | 0.138 | 0.16 | Dihydroorotate oxidase inhibitor | 0.16 0.003 DBMET02125 | DBMET02125 | |
| 0.123 | 0.229 | 0.174 | Hypoglycemic | 0.174 0.142 DBMET00748 | DBMET00748 | |
| 0.06 | 0.167 | 0.205 | Xanthine oxidase inhibitor | 0.205 0.018 DBMET00748 0.091 0.069 DBMET02125 | DBMET00748 | |
| 0.089 | 0.202 | 0.176 | Anesthetic general | 0.176 0.09 DBMET02125 | DBMET02125 | |
| 0.024 | 0.142 | 0.049 | Kainate receptor agonist | 0.049 0.015 DBMET02125 | DBMET02125 | |
| 0.012 | 0.135 | 0.032 | Thyroid hormone agonist | 0.032 0.011 DBMET02125 | DBMET02125 | |
| 0.017 | 0.144 | 0.062 | Aldose reductase inhibitor | 0.062 0.031 DBMET02125 | DBMET02125 | |
| 0.007 | 0.134 | 0.019 | Thyroid hormone alpha agonist | 0.019 0.008 DBMET02125 | DBMET02125 | |
| 0.014 | 0.155 | 0.055 | Adenosine A2b receptor antagonist | 0.055 0.029 DBMET02125 | DBMET02125 | |
| 0.025 | 0.166 | 0.065 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.065 0.035 DBMET00748 | DBMET00748 | |
| 0.116 | 0.264 | 0.312 | 5 Hydroxytryptamine release stimulant | 0.312 0.066 DBMET02125 | DBMET02125 | |
| 0.003 | 0.172 | 0.029 | Kainate receptor 1 antagonist | 0.029 0.011 DBMET02125 | DBMET02125 | |
| 0.028 | 0.2 | 0.052 | Antiviral (Hepatitis D) | 0.052 0.033 DBMET02125 | DBMET02125 | |
| 0.014 | 0.188 | 0.068 | Xanthine dehydrogenase inhibitor | 0.05 0.046 DBMET00748 0.068 0.033 DBMET02125 | DBMET02125 | |
| 0.029 | 0.202 | 0.104 | Cyclin-dependent kinase 1 inhibitor | 0.104 0.063 DBMET02125 | DBMET02125 | |
| 0.009 | 0.184 | 0.02 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.02 0.019 DBMET02125 | DBMET02125 | |
| 0.085 | 0.266 | 0.148 | MAP kinase 3 inhibitor | 0.148 0.07 DBMET02125 | DBMET02125 | |
| 0.002 | 0.187 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 DBMET02125 | DBMET02125 | |
| 0.026 | 0.215 | 0.081 | Phospholipase D inhibitor | 0.081 0.033 DBMET02125 | DBMET02125 | |
| 0.015 | 0.217 | 0.053 | Alcohol oxidase inhibitor | 0.053 0.042 DBMET02125 | DBMET02125 | |
| 0.009 | 0.216 | 0.045 | Acid ceramidase inhibitor | 0.045 0.004 DBMET02125 | DBMET02125 | |
| 0.062 | 0.291 | 0.195 | Anticonvulsant | 0.195 0.086 DBMET02125 | DBMET02125 | |
| 0.077 | 0.306 | 0.164 | CF transmembrane conductance regulator agonist | 0.164 0.054 DBMET02125 | DBMET02125 | |
| 0.005 | 0.236 | 0.06 | Kainate receptor antagonist | 0.06 0.016 DBMET02125 | DBMET02125 | |
| 0.047 | 0.282 | 0.141 | Nav1.1 sodium channel blocker | 0.141 0.037 DBMET02125 | DBMET02125 | |
| 0.015 | 0.254 | 0.066 | Protein kinase (CK2) beta inhibitor | 0.066 0.005 DBMET02125 | DBMET02125 | |
| 0.007 | 0.25 | 0.045 | Nicotinic acid receptor 2 antagonist | 0.045 0.004 DBMET02125 | DBMET02125 | |
| 0.115 | 0.358 | 0.211 | Nitric-oxide synthase stimulant | 0.211 0.072 DBMET02125 | DBMET02125 | |
| 0.002 | 0.253 | 0.014 | Egl nine homolog 3 inhibitor | 0.014 0.006 DBMET02125 | DBMET02125 | |
| 0.008 | 0.26 | 0.04 | Nicotinic acid receptor 2 agonist | 0.04 0.02 DBMET02125 | DBMET02125 | |
| 0.024 | 0.279 | 0.064 | Pregnane X receptor antagonist | 0.064 0.023 DBMET02125 | DBMET02125 | |
| 0.065 | 0.331 | 0.289 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.289 0.039 DBMET02125 | DBMET02125 | |
| 0.011 | 0.28 | 0.062 | Nerve growth factor antagonist | 0.062 0.008 DBMET02125 | DBMET02125 | |
| 0.053 | 0.323 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.097 DBMET02125 | DBMET02125 | |
| 0.031 | 0.307 | 0.084 | Keratolytic | 0.084 0.044 DBMET02125 | DBMET02125 | |
| 0.015 | 0.305 | 0.046 | GABA B receptor antagonist | 0.046 0.025 DBMET02125 | DBMET02125 | |
| 0.005 | 0.295 | 0.069 | CDK2/cyclin E inhibitor | 0.069 0.035 DBMET02125 | DBMET02125 | |
| 0.038 | 0.33 | 0.089 | MDM2 inhibitor | 0.089 0.012 DBMET02125 | DBMET02125 | |
| 0.007 | 0.304 | 0.041 | Neurokinin 1 antagonist | 0.041 0.028 DBMET02125 | DBMET02125 | |
| 0.029 | 0.329 | 0.171 | GABA C receptor agonist | 0.171 0.027 DBMET02125 | DBMET02125 | |
| 0.08 | 0.381 | 0.361 | Angiogenesis inhibitor | 0.361 0.066 DBMET02125 | DBMET02125 | |
| 0.044 | 0.35 | 0.163 | TRKC antagonist | 0.163 0.091 DBMET02125 | DBMET02125 | |
| 0.001 | 0.308 | 0.009 | DNA topoisomerase III inhibitor | 0.009 0.004 DBMET02125 | DBMET02125 | |
| 0.037 | 0.354 | 0.249 | EphB2 antagonist | 0.249 0.057 DBMET02125 | DBMET02125 | |
| 0.102 | 0.422 | 0.3 | Calcium channel activator | 0.3 0.092 DBMET02125 | DBMET02125 | |
| 0.031 | 0.352 | 0.104 | Beta glucuronidase inhibitor | 0.104 0.063 DBMET02125 | DBMET02125 | |
| 0.013 | 0.337 | 0.055 | Nicotinic acid receptor 1 agonist | 0.055 0.018 DBMET02125 | DBMET02125 | |
| 0.029 | 0.36 | 0.156 | HIV-1 integrase (Overall Integration) inhibitor | 0.156 0.023 DBMET02125 | DBMET02125 | |
| 0.013 | 0.345 | 0.061 | Adenylate cyclase 1 inhibitor | 0.061 0.017 DBMET02125 | DBMET02125 | |
| 0.059 | 0.396 | 0.157 | Growth hormone agonist | 0.157 0.082 DBMET02125 | DBMET02125 | |
| 0.017 | 0.354 | 0.055 | Glutamate (mGluR4) antagonist | 0.055 0.017 DBMET02125 | DBMET02125 | |
| 0.004 | 0.346 | 0.031 | Kainate receptor 2 antagonist | 0.031 0.029 DBMET02125 | DBMET02125 | |
| 0.024 | 0.367 | 0.094 | Creatine kinase inhibitor | 0.094 0.067 DBMET02125 | DBMET02125 | |
| 0.009 | 0.362 | 0.085 | Acetylcholine M5 receptor agonist | 0.085 0.03 DBMET02125 | DBMET02125 | |
| 0.016 | 0.375 | 0.084 | Pim-1 kinase inhibitor | 0.084 0.075 DBMET02125 | DBMET02125 | |
| 0.011 | 0.374 | 0.069 | Catalase inhibitor | 0.069 0.056 DBMET02125 | DBMET02125 | |
| 0.012 | 0.38 | 0.048 | Aconitate hydratase inhibitor | 0.048 0.043 DBMET02125 | DBMET02125 | |
| 0.011 | 0.38 | 0.146 | Protein kinase (CK2) inhibitor | 0.146 0.034 DBMET02125 | DBMET02125 | |
| 0.006 | 0.383 | 0.051 | Nicotinic acid receptor agonist | 0.051 0.014 DBMET02125 | DBMET02125 | |
| 0.013 | 0.39 | 0.145 | Phosphodiesterase III inhibitor | 0.145 0.011 DBMET02125 | DBMET02125 | |
| 0.008 | 0.388 | 0.069 | Dihydroorotate dehydrogenase inhibitor | 0.069 0.022 DBMET02125 | DBMET02125 | |
| 0.011 | 0.401 | 0.081 | Leucine-rich repeat kinase 2 inhibitor | 0.081 0.057 DBMET02125 | DBMET02125 | |
| 0.02 | 0.41 | 0.063 | Corticotropin releasing factor 2 receptor antagonist | 0.063 0.041 DBMET02125 | DBMET02125 | |
| 0.051 | 0.443 | 0.24 | Tumour necrosis factor antagonist | 0.24 0.034 DBMET02125 | DBMET02125 | |
| 0.074 | 0.469 | 0.211 | Histamine release inhibitor | 0.211 0.19 DBMET00748 | DBMET00748 | |
| 0.008 | 0.402 | 0.027 | Glutamate (mGluR1) agonist | 0.027 0.013 DBMET02125 | DBMET02125 | |
| 0.039 | 0.45 | 0.235 | Aldehyde oxidase inhibitor | 0.235 0.088 DBMET02125 | DBMET02125 | |
| 0.034 | 0.451 | 0.145 | Cyclin-dependent kinase 8 inhibitor | 0.145 0.084 DBMET02125 | DBMET02125 | |
| 0.015 | 0.437 | 0.04 | Glutamate (mGluR group III) antagonist | 0.04 0.039 DBMET02125 | DBMET02125 | |
| 0.048 | 0.475 | 0.174 | ATPase inhibitor | 0.174 0.065 DBMET02125 | DBMET02125 | |
| 0.026 | 0.46 | 0.123 | Electrolyte absorption antagonist | 0.123 0.034 DBMET02125 | DBMET02125 | |
| 0.011 | 0.451 | 0.071 | Lipase inhibitor | 0.071 0.053 DBMET02125 | DBMET02125 | |
| 0.018 | 0.463 | 0.126 | GABA C receptor antagonist | 0.126 0.047 DBMET02125 | DBMET02125 | |
| 0.014 | 0.461 | 0.075 | Glutamate (mGluR7) antagonist | 0.075 0.035 DBMET02125 | DBMET02125 | |
| 0.009 | 0.464 | 0.114 | Pim-3 kinase inhibitor | 0.114 0.034 DBMET02125 | DBMET02125 | |
| 0.021 | 0.481 | 0.092 | Exportin-1 inhibitor | 0.092 0.014 DBMET02125 | DBMET02125 | |
| 0.01 | 0.471 | 0.081 | Vanilloid 1 antagonist | 0.081 0.036 DBMET02125 | DBMET02125 | |
| 0.032 | 0.494 | 0.137 | Peroxidase inhibitor | 0.137 0.086 DBMET02125 | DBMET02125 | |
| 0.02 | 0.483 | 0.19 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.19 0.084 DBMET02125 | DBMET02125 | |
| 0.003 | 0.469 | 0.024 | Glutamate (mGluR1a) agonist | 0.024 0.013 DBMET02125 | DBMET02125 | |
| 0.053 | 0.521 | 0.162 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.162 0.116 DBMET02125 | DBMET02125 | |
| 0.023 | 0.494 | 0.098 | MAP kinase 13 inhibitor | 0.098 0.084 DBMET02125 | DBMET02125 | |
| 0.007 | 0.48 | 0.064 | Dihydroorotase inhibitor | 0.064 0.014 DBMET02125 | DBMET02125 | |
| 0.003 | 0.475 | 0.027 | Nicotinic alpha3beta4 receptor agonist | 0.027 0.026 DBMET02125 | DBMET02125 | |
| 0.019 | 0.495 | 0.208 | MAP kinase kinase 2 inhibitor | 0.208 0.077 DBMET02125 | DBMET02125 | |
| 0.013 | 0.497 | 0.095 | Polo-like kinase-4 inhibitor | 0.095 0.082 DBMET02125 | DBMET02125 | |
| 0.015 | 0.503 | 0.086 | MAP kinase kinase 1 inhibitor | 0.086 0.077 DBMET02125 | DBMET02125 | |
| 0.019 | 0.513 | 0.192 | Nav1.6 sodium channel blocker | 0.192 0.022 DBMET02125 | DBMET02125 | |
| 0.08 | 0.583 | 0.289 | 5 Hydroxytryptamine release inhibitor | 0.289 0.178 DBMET02125 | DBMET02125 | |
| 0.003 | 0.509 | 0.051 | AMPA receptor antagonist | 0.051 0.03 DBMET02125 | DBMET02125 | |
| 0.008 | 0.516 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.031 DBMET02125 | DBMET02125 | |
| 0.005 | 0.518 | 0.038 | Purinergic P2X7 antagonist | 0.038 0.023 DBMET02125 | DBMET02125 | |
| 0.044 | 0.559 | 0.22 | Superoxide dismutase inhibitor | 0.22 0.097 DBMET02125 | DBMET02125 | |
| 0.018 | 0.535 | 0.095 | GABA C receptor rho-1 antagonist | 0.095 0.07 DBMET02125 | DBMET02125 | |
| 0.016 | 0.535 | 0.045 | Bombesin 2 receptor antagonist | 0.045 0.041 DBMET02125 | DBMET02125 | |
| 0.015 | 0.539 | 0.152 | Ferrochelatase inhibitor | 0.152 0.037 DBMET02125 | DBMET02125 | |
| 0.009 | 0.541 | 0.06 | Aryl hydrocarbon receptor antagonist | 0.06 0.053 DBMET02125 | DBMET02125 | |
| 0.013 | 0.555 | 0.105 | M18 aspartyl aminopeptidase inhibitor | 0.105 0.085 DBMET02125 | DBMET02125 | |
| 0.031 | 0.574 | 0.154 | GABA C receptor rho-2 antagonist | 0.154 0.068 DBMET02125 | DBMET02125 | |
| 0.017 | 0.563 | 0.139 | I kappa B kinase epsilon inhibitor | 0.139 0.132 DBMET02125 | DBMET02125 | |
| 0.005 | 0.551 | 0.056 | NMDA receptor glycine site agonist | 0.056 0.05 DBMET02125 | DBMET02125 | |
| 0.004 | 0.558 | 0.039 | CDK5/p25 inhibitor | 0.039 0.032 DBMET02125 | DBMET02125 | |
| 0.01 | 0.568 | 0.112 | MAP kinase kinase inhibitor | 0.112 0.082 DBMET02125 | DBMET02125 | |
| 0.008 | 0.566 | 0.12 | Glycogen synthase kinase-3 alpha inhibitor | 0.12 0.085 DBMET02125 | DBMET02125 | |
| 0.007 | 0.578 | 0.094 | Vascular endothelial growth factor 2 antagonist | 0.094 0.076 DBMET02125 | DBMET02125 | |
| 0.018 | 0.591 | 0.184 | Tyrosine kinase inhibitor | 0.184 0.074 DBMET02125 | DBMET02125 | |
| 0.013 | 0.586 | 0.093 | Myeloperoxidase inhibitor | 0.093 0.044 DBMET02125 | DBMET02125 | |
| 0.01 | 0.585 | 0.106 | Vascular endothelial growth factor antagonist | 0.106 0.077 DBMET02125 | DBMET02125 | |
| 0.002 | 0.581 | 0.037 | Methionyl aminopeptidase 1 inhibitor | 0.037 0.015 DBMET02125 | DBMET02125 | |
| 0.031 | 0.61 | 0.185 | 3C-like protease (Human coronavirus) inhibitor | 0.185 0.061 DBMET02125 | DBMET02125 | |
| 0.011 | 0.601 | 0.112 | Vascular endothelial growth factor 3 antagonist | 0.112 0.103 DBMET02125 | DBMET02125 | |
| 0.04 | 0.646 | 0.155 | Neurotensin receptor agonist | 0.155 0.09 DBMET02125 | DBMET02125 | |
| 0.018 | 0.629 | 0.129 | Nav1.2 sodium channel blocker | 0.129 0.074 DBMET02125 | DBMET02125 | |
| 0.012 | 0.626 | 0.151 | 5 Hydroxytryptamine 3A agonist | 0.151 0.035 DBMET02125 | DBMET02125 | |
| 0.008 | 0.623 | 0.127 | CDC-like kinase 2 inhibitor | 0.127 0.111 DBMET02125 | DBMET02125 | |
| 0.018 | 0.642 | 0.136 | Nav1.3 sodium channel blocker | 0.136 0.058 DBMET02125 | DBMET02125 | |
| 0.01 | 0.642 | 0.045 | Aldosterone antagonist | 0.045 0.037 DBMET02125 | DBMET02125 | |
| 0.044 | 0.685 | 0.387 | GABA C receptor rho-3 antagonist | 0.387 0.067 DBMET02125 | DBMET02125 | |
| 0.004 | 0.65 | 0.047 | Histamine H1 receptor agonist | 0.047 0.024 DBMET02125 | DBMET02125 | |
| 0.008 | 0.658 | 0.257 | Aryl hydrocarbon receptor agonist | 0.257 0.076 DBMET02125 | DBMET02125 | |
| 0.011 | 0.673 | 0.058 | Phosphodiesterase 1A inhibitor | 0.058 0.047 DBMET02125 | DBMET02125 | |
| 0.013 | 0.695 | 0.085 | Bromodomain-containing protein 2 inhibitor | 0.085 0.065 DBMET02125 | DBMET02125 | |
| 0.004 | 0.696 | 0.056 | Collagenase 3 inhibitor | 0.056 0.047 DBMET02125 | DBMET02125 | |
| 0.013 | 0.71 | 0.163 | Focal adhesion kinase 2 inhibitor | 0.163 0.11 DBMET02125 | DBMET02125 | |
| 0.008 | 0.716 | 0.114 | Sphingosine 1-phosphate receptor 2 antagonist | 0.114 0.113 DBMET02125 | DBMET02125 | |
| 0.011 | 0.722 | 0.103 | Nav1.5 sodium channel blocker | 0.103 0.079 DBMET02125 | DBMET02125 | |
| 0.002 | 0.718 | 0.059 | Alpha 1d adrenoreceptor antagonist | 0.059 0.042 DBMET02125 | DBMET02125 | |
| 0.003 | 0.723 | 0.07 | Alpha 1b adrenoreceptor antagonist | 0.07 0.053 DBMET02125 | DBMET02125 | |
| 0.065 | 0.794 | 0.198 | 5 Hydroxytryptamine 3E antagonist | 0.198 0.066 DBMET02125 | DBMET02125 | |
| 0.013 | 0.745 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | 0.126 0.109 DBMET02125 | DBMET02125 | |
| 0.006 | 0.738 | 0.077 | MAP kinase kinase 10 inhibitor | 0.077 0.032 DBMET02125 | DBMET02125 | |
| 0.003 | 0.741 | 0.081 | TRPA1 antagonist | 0.081 0.025 DBMET02125 | DBMET02125 | |
| 0.023 | 0.764 | 0.187 | Gastrin inhibitor | 0.187 0.168 DBMET02125 | DBMET02125 | |
| 0.006 | 0.748 | 0.097 | Polo-like kinase-1 inhibitor | 0.097 0.049 DBMET02125 | DBMET02125 | |
| 0.023 | 0.77 | 0.235 | Insulysin inhibitor | 0.235 0.111 DBMET02125 | DBMET02125 | |
| 0.004 | 0.766 | 0.134 | LIM domain kinase 1 inhibitor | 0.134 0.115 DBMET02125 | DBMET02125 | |
| 0.004 | 0.792 | 0.063 | Raf kinase inhibitor | 0.063 0.061 DBMET02125 | DBMET02125 | |
| 0.015 | 0.821 | 0.096 | Phosphodiesterase 7B inhibitor | 0.096 0.061 DBMET02125 | DBMET02125 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |